Literature DB >> 10418648

Use of Anaesthesia Simulator: initial impressions of its use in two Belgian University Centers.

R Larbuisson1, P Pendeville, A S Nyssen, M Janssens, A Mayné.   

Abstract

459 trainees in Anesthesia and Intensive Care Medicine, accompanied by fully certified specialists from several Belgian University Hospital Centers, spend at least a 3 hour session at the Anaesthesia Simulator. Each session comprises three segments: the briefing, the simulation session and the debriefing. The use of simulations allows significant individualization of the learning experience. The simulator helps to develop the capacity to understand, explain a phenomenon and to resolve problems. Another important aspect of the use of the simulator involves the trainee's "right to make mistakes". This allows to widen the spectrum of executional situations, and decreases the number of dangerous situations. Two University Centers (ULg and UCL) have each organized simulator sessions despite some differences in their approaches. The simulator is a teaching tool worthy of an obligatory role in the most up-to-date training possible of modern anesthesiologist. This is all the more important given that the current practice of anesthesiology is so complex that any error could cost a human life.

Entities:  

Mesh:

Year:  1999        PMID: 10418648

Source DB:  PubMed          Journal:  Acta Anaesthesiol Belg        ISSN: 0001-5164


  2 in total

1.  Multidisciplinary simulation training for endotracheal intubation during COVID-19 in one Hong Kong regional hospital: strengthening of existing procedures and preparedness.

Authors:  Eric H K So; N H Chia; George W Y Ng; Osburga P K Chan; S L Yuen; David C Lung; W C Li; S S So; Victor K L Cheung
Journal:  BMJ Simul Technol Enhanc Learn       Date:  2021-05-25

2.  Using simulation for training and to change protocol during the outbreak of severe acute respiratory syndrome.

Authors:  Simon D Abrahamson; Sonya Canzian; Fabrice Brunet
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.